Exploring the link between imaging and tumor environment in urologic cancer

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational cohort study aims to investigate how imaging data correlates with the tumor microenvironment and prognosis in patients with urologic cancer. It will involve patients treated at Wuhan Union Hospital who have undergone CT or MRI scans prior to treatment. The study will analyze the relationship between imaging characteristics and tumor biology to better understand patient outcomes. By focusing on a specific patient population over a defined period, the study seeks to provide insights into the prognostic value of imaging in urologic cancers.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Patients treated for urologic cancer in Wuhan Union Hospital from August 2024 to August 2027;
2. Aged \> 18 years old;
3. At least one CT scan or MRI scan before treatment;
4. Tissue biopsy pathological examination confirmed the diagnosis of the above tumors.

Exclusion criteria：

1. Poor image quality;
2. Incomplete clinical data or loss of follow-up;
3. Presence of another primary malignancy other than urologic cancer;
4. Unclear pathological diagnosis。

Where it's running

• Union Hospital，Tongji Medical College，Huazhong University of Science and Technology
  Wuhan, Hubei, China Recruiting

Study contacts

• Study coordinator: Lian Yang
• Email: yanglian@hust.edu.cn
• Phone: 18986273791

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Predicting heart injury after non-cardiac surgery in urologic cancer patients

  Doctors are testing whether AI analysis of a preoperative ECG can identify which urologic cancer patients are at higher risk of heart injury or major heart problems after non-cardiac surgery.

  Recruiting Korea University Anam Hospital · Seoul · NCT07634666

• Blood extracellular vesicles to detect chemotherapy-related nerve damage.

  We will test whether tiny blood particles called extracellular vesicles can predict who will develop chemotherapy-induced peripheral neuropathy in adults receiving taxane, platinum, or antimitotic chemotherapy.

  Recruiting Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico · Milan · NCT07558447

• Web app for reporting side effects during radiation therapy

  This project will try a web app that lets people receiving radiation for breast, gynecologic, or urologic cancers report symptoms and quality of life so clinicians can spot problems earlier.

  Recruiting Institute of Oncology Ljubljana · Ljubljana · NCT07416630

• Vaginal Dilator Therapy After Pelvic Radiation

  This study tests a new behavioral program to help women who had pelvic radiation use vaginal dilators more regularly.

  Recruiting Duke University · Durham, North Carolina · NCT07216456

• Palliative radiotherapy for pelvic soft tissue tumors

  This study is testing if giving fewer doses of palliative radiotherapy can help relieve symptoms and improve quality of life for patients with pelvic soft tissue tumors from gastrointestinal, urological, or gynecological cancers.

  Recruiting at 11 sites Sykehuset Telemark · Ålesund and 10 other locations · NCT06398314

• Improving quality of life for patients undergoing urological surgery

  This study is testing whether using personalized questionnaires can help improve the quality of life and recovery for patients having urological surgery.

  Recruiting Medical University of Graz · Graz, Styria · NCT06397287

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.